Micro Developing Active

H.C. Wainwright mantiene il rating Buy su Lexicon Pharmaceuticals

Punteggio
0,3
Velocità
▲ 0,0
Articoli
6
Fonti
2

Riepilogo

Un articolo appartiene a questa narrazione se discute del rating Buy e del prezzo obiettivo di H.C. Wainwright per Lexicon Pharmaceuticals.

Articoli Correlati

Tempus AI Inc. (TEM) Touted as a Buy Amid Focus on Healthcare Opportunities

Yahoo Finance · Mar 25, 2026
Mixed

Fonti

Why Calumet Stock Is Soaring Today Nasdaq
AudioEye (AEYE) Gains from DOJ Accessibility Mandate Tailwinds Despite Price … Yahoo Finance
H.C. Wainwright Bullish on Altimmune (ALT) Amid Growing Focus on … Yahoo Finance
Tempus AI Inc. (TEM) Touted as a Buy Amid Focus … Yahoo Finance

Cronologia

Ultimo aggiornamento Mar 22, 2026